Pancreatic Cancer: What the ESPAC-4 Randomized Adjuvant Chemotherapy Trial Tells Us

Researchers examine patterns of recurrence after resection of pancreatic ductal adenocarcinoma.  

Source: CancerNetwork - October 11, 2019 Category: Cancer & Oncology Authors: Leanne Marcello, MS Source Type: news